HealthQuill AIDS
HIV vaccine trials conducted in Eastern and Southern Africa threw up surprising results when more infections were reported in the two vaccine groups than in the placebo or dummy group.
Drugs Health Pharma

PrEPVacc HIV trials’ results ‘surprising’ as dummy group clocks less infections

HIV vaccine trials conducted in Eastern and Southern Africa threw up surprising results when more infections were reported in the two vaccine groups.

Read More
A person dies every minute due to AIDS-related causes, and the world is off-track to achieve its goals with a quarter of 39.9 million HIV people not able to receive treatment owing to a shortage of funds and an anti-rights push, a report stated.
Drugs Health Pharma

Fund crunch, anti-rights push, slowing global target to end AIDS, UN says

A person dies every minute due to AIDS-related causes, and the world is off-track to achieve its goals with a quarter of 39.9.

Read More
US-based Varda Space Industries’ spacecraft in orbit crystallised a metastable form of a drug for HIV/AIDS — furthering the feasibility of processing pharmaceuticals in microgravity.
Drugs Health Pharma

US-based Varda Space crystallises HIV drug in microgravity

 HQ Team March 31, 2024: US-based Varda Space Industries’ spacecraft in orbit crystallised a metastable form of a drug for HIV/AIDS — furthering.

Read More
British pharmaceutical firm, GSK Plc., has got marketing authorization from the European Medicines Authority for its injectable, and tablets, cabotegravir, to prevent HIV.
Drugs Health Pharma

Britain’s GSK gets EMA clearance for drug to prevent HIV 

HQ Team July 24, 2023: British pharmaceutical firm, GSK Plc., has got marketing authorization from the European Medicines Authority for its injectable, and.

Read More
The reliance of countries on external support for funding initiatives to combat HIV is worrisome, and though new infections and deaths are falling, some nations are experiencing rising incidence, the WHO stated.
Drugs Health Pharma

Challenges to fight HIV remain, funding ‘precarious’: WHO

HQ Team July 24, 2023: The reliance of countries on external support for funding initiatives to combat HIV is worrisome, and though new.

Read More
The FDA has approved the first daily oral contraceptive pill, Opill, without prescription to be sold in the US, according to a statement from the regulator.
Drugs Health Pharma

USFDA allows first oral contraceptive without a prescription 

HQ Team July 14, 2023: The FDA has approved the first daily oral contraceptive pill, Opill, without prescription to be sold in the.

Read More
Aurobindo Pharma, an Indian maker of generic pharmaceuticals and active pharmaceutical ingredients, announced it signed a voluntary sub-licensing with a UN body for developing and marketing a drug to prevent HIV.
Drugs Health Medical Pharma

Aurobindo Pharma signs licensing pact with UN body to fight HIV

Aurobindo Pharma, an Indian maker of generic pharmaceuticals and active pharmaceutical ingredients, announced it signed a voluntary sub-licensing with a UN body for.

Read More
Maternal deaths have risen or stagnated globally over recent years, and every two minutes, a woman dies during pregnancy or childbirth, according to the WHO.
Drugs Health Pharma

‘Every two minutes, a woman dies during childbirth, pregnancy’

Maternal deaths have risen or stagnated globally over recent years, and every two minutes, a woman dies during pregnancy or childbirth, according to.

Read More
Twelve African nations have drawn out a blueprint to stop AIDS in children by 2030, a move welcomed by the United Nations.
Drugs Medical Pharma

12 African nations commit to end AIDS in children by 2030

Twelve African nations have drawn out a blueprint to stop AIDS in children by 2030, a move welcomed by the United Nations.

Read More
Lupin, headquartered in Mumbai, India, has received tentative approval from the FDA under the US President’s Emergency Plan for AIDS Relief for its New Drug Application for three drugs.
Drugs Medical Pharma

Lupin gets tentative nod for three HIV drugs

Lupin, headquartered in Mumbai, India, has received tentative approval from the FDA under the US President’s Emergency Plan for AIDS Relief for its.

Read More
X